EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Pancreatic Lipase Inhibitors: Mechanistic Foundations, Structural Insights, and Emerging Medicinal Chemistry Strategies

Neil Birekumar Panchal, Vipul Manusinh Vaghela

Biosciences Biotechnology Research Asia · 31.03.2026 · 1 (23) · 1

DOI: 10.13005/bbra/3478 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Biosciences Biotechnology Research Asia, online erschienen am 30.03.2026. Verfasst von Neil Birekumar Panchal und 1 weiteren Autor:innen. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 140 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The main dietary triglyceride hydrolyzing catalyst, and a long time pharmacological parameter of decreased dietary caloric intake, is pancreatic lipase (PL). Recent progress in structural biology, high resolution crystalography and computational models has given a new understanding of the catalytic triad of PL and interfacial activation, lid dynamics and stabilization of colipase dependent. These mechanistic underpinnings have facilitated more rational search of the varied classes of inhibitors including covalent β-lactones to reversible natural products (flavonoids, aurones, chalcones) and contemporary synthetic scaffolds like thiazolidinedione, triazole, and multi-target hybrid chemotypes. The mechanism by which the inhibitors interact with the hydrophobic acyl-binding tunnel, oxyanion hole, and aromatic platform around Ser152 is now understood using quantitative structure-activity correlations, molecular docking, molecular dynamics simulations, and pharmacophore models. The new approaches to medicinal chemistry, such as allosteric inhibition of lid movement, partial inhibition to enhance the safety, the investigation of non-2-lactone electrophiles, and AI-assisted scaffold discovery provide avenues to effective, yet safer inhibitors. The enzymatic mechanism, structural biology, SAR trends, and computational methods have been incorporated in this review to present a single framework in designing next-generation pancreatic lipase inhibitors.

Zitieren

APA

Panchal, N. B., & Vaghela, V. M. (2026). Pancreatic Lipase Inhibitors: Mechanistic Foundations, Structural Insights, and Emerging Medicinal Chemistry Strategies. Biosciences Biotechnology Research Asia, 1(23), 1. https://doi.org/10.13005/bbra/3478

Vancouver

Panchal NB, Vaghela VM. Pancreatic Lipase Inhibitors: Mechanistic Foundations, Structural Insights, and Emerging Medicinal Chemistry Strategies. Biosciences Biotechnology Research Asia. 2026;1(23):1. doi:10.13005/bbra/3478

BibTeX
@article{Panchal2026,
  author = {Panchal, Neil Birekumar and Vaghela, Vipul Manusinh},
  title = {Pancreatic Lipase Inhibitors: Mechanistic Foundations, Structural Insights, and Emerging Medicinal Chemistry Strategies},
  journal = {Biosciences Biotechnology Research Asia},
  year = {2026},
  volume = {1},
  number = {23},
  pages = {1},
  doi = {10.13005/bbra/3478}
}
Kostenlos starten →